Kilitch Drugs India Ltd - 524500 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release relating to Financial Results for Financial Year 2018-19.30-05-2019
30-05-2019
Kilitch Drugs India Ltd - 524500 - Board recommends Final Dividend
Kilitch Drugs India Ltd has informed BSE that the Board of Directors of the Company at its Meeting held on May 30, 2019, inter alia, have recommended a final dividend of Re. 0.50/- per equity share (face value of Rs. 10/- each) for the financial year 2018-19, subject to the approval of the Members at the ensuing Annual General Meeting ("AGM") of the Company. The dividend, if approved by the Members shall be paid within 30 days from the date of AGM.30-05-2019
Kilitch Drugs India Ltd - 524500 - Outcome of Board Meeting
Outcome Of Board Meeting - Financial Results for the quarter and year ended 31st March, 2019 and Recommendation of Dividend30-05-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm Deep Shukla & Associates 4 Name of the Certifying Individual Deep Shukla 5Membership TypeFCS 6 Membership Number 5652 7 CP No. 5364 8 Whether any observations/qualification reported by the Secretarial Auditor ? NO29-05-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Board to consider Dividend
With reference to the earlier letter dated May 22, 2019, Kilitch Drugs India Ltd has now informed BSE that Board of Directors may consider to recommend the dividend at their meeting scheduled to be held on May 30, 2019.27-05-2019
KILITCH DRUGS (INDIA) LTD. - 524500 - Update on board meeting
The Board Meeting to be held on 30/05/2019 has been revised to 30/05/2019 In furtherance to our letter dated 22nd May, 2019 we wish to inform you that Board of Directors may consider to recommend the dividend at their meeting scheduled to be held on Thursday, 30th May, 2019 at its Corporate office at 37, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai-400088, Maharashtra, India.27-05-2019
Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201522-05-2019
Kilitch Drugs India Ltd - 524500 - Board Meeting Intimation for To Consider And Approve The Standalone And Consolidated Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2019.
KILITCH DRUGS (INDIA) LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and Financial year ended March 31, 2019.22-05-2019
Kilitch Drugs India Ltd - 524500 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201515-05-2019